CDC Data Show Cancer, Heart Disease Mortality Trending Down

Troy Brown, RN

June 11, 2019

The Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS) has released current quarterly data of provisional mortality rates for several top causes of death in the United States. The data show cancer and heart disease trended downward in the last quarter of 2018.

The data provide the first estimated, or provisional, mortality rates for 2018 for disease-related top causes of death. This quarter's release do not contain full-year 2018 provisional death rates for external causes of death, including drug overdoses, homicide, firearm mortality, and suicide.

In addition, the report includes only death rates — the number of deaths per 100,000 population — not whole death numbers.

"Estimates for the 12-month period ending with a specific quarter include all seasons of the year and, thus, are insensitive to seasonality," the authors write.

All-Cause Mortality

The crude mortality rate for all causes was 859.7 in the fourth quarter of 2018 (2018 Q4). This is lower than the crude death rate of 875.2 for the fourth quarter of 2017. The crude mortality rate for all causes for the 12 months ending 2018 Q4 was 864.2, which is close to the rate of 863.8 for the 12 months ending 2017 Q4.

The age-adjusted death rate for all causes was 711.8 during 2018 Q4; this is lower than the age-adjusted mortality rate of 735.6 in 2017 Q4. The age-adjusted all-cause death rate for the 12 months ending with 2018 Q4 was 720.2 — lower than that of 731.9 for the 12 months ending with 2017 Q4.

Alzheimer Disease

The crude death rate for Alzheimer disease was 37.8 in 2018 Q4, compared with 38.7 in 2017 Q4. The crude mortality rate for Alzheimer disease for the 12 months ending in 2018 Q4 was 37.2 — similar to 37.3 the year before.

The age-adjusted mortality rate for Alzheimer disease was 30.8 in 2018 Q4, lower than the age-adjusted rate of 31.9 in 2017 Q4. The age-adjusted death rate for Alzheimer disease for the 12 months ending with 2018 Q4 was 30.4 — lower than that of 31.0 for the 12 months ending with 2017 Q4.

Cancer

The crude mortality rate for cancer was 183.9 in 2018 Q4, which was lower than that of 185.3 the year before. The crude cancer death rate was 182.5 for the 12 months ending 2018 Q4, which is lower than that of 183.9 for the 12 months ending with 2017 Q4.

The age-adjusted mortality rate for cancer was 148.8 in 2018 Q4 — lower than that of 152.4 in 2017 Q4. The age-adjusted mortality rate for the 12 months ending with 2018 Q4 was 148.5, lower than that of 152.5 for the 12 months ending with 2017 Q4.

Chronic Liver Disease and Cirrhosis

The crude mortality rate for chronic liver disease and cirrhosis was 13.0 in 2018 Q4, compared with the crude death rate of 13.3 in 2017 Q4. The crude death rate for chronic liver disease and cirrhosis for the 12 months ending with 2018 Q4 was 13.0, just higher than the 12.8 for the 12-month period ending with 2017 Q4.

The age-adjusted mortality rate for chronic liver disease and cirrhosis was 11.0 in 2018 Q4 — lower than that of 11.3 in 2017 Q4. The age-adjusted mortality rate for chronic liver disease and cirrhosis for the 12 months ending with 2018 Q4 11.0, similar to the 10.9 for 2017 Q4.

Chronic Lower Respiratory Diseases

The crude death rate for chronic lower respiratory diseases was 45.7 in 2018 Q4, lower than the rate of 47.7 in 2017 Q4. The crude mortality rate for chronic lower respiratory diseases for the 12 months ending with 2018 Q4 was 48.5 — lower than the crude mortality rate of 49.2 for the 12 months ending 2017 Q4.

The age-adjusted mortality rate for chronic lower respiratory diseases was 37.0 in 2018 Q4 — lower than that of 39.3 in 2017 Q4. The age-adjusted death rate over the 12 months ending 2018 Q4 was 39.5 — lower than the age-adjusted death rate of 40.9 for the 12 months ending 2017 Q4.

Diabetes

The crude mortality rate for diabetes was 26.0 in 2018 Q4, compared with 26.6 in 2017 Q4. The crude mortality rate for diabetes during the 12 months ending 2018 Q4 was 25.8, similar to the 25.7 for the 12 months ending 2017 Q4.

The age-adjusted death rate for diabetes was 21.2 in 2018 Q4, slightly lower than the 22.0 in 2017 Q4. The age-adjusted death rate for diabetes was 21.5 during the 12 months ending with 2017 Q4.

Drug Overdose

The crude mortality rate for drug overdose fell just slightly from 20.4 in 2018 Q2 to 21.9 in 2017 Q2.

For the 12 months ending with 2018 Q2, the crude death rate was 20.7, compared with 21.2 for the 12 months ending with 2017 Q2.

The age-adjusted death rate for overdose rose from 20.5 in 2018 Q2 to 22.1 in 2017 Q2. The age-adjusted mortality rate for drug overdose for the 12 months ending with 2018 Q2 as 20.8, lower than the 21.3 for the 12 months ending with 2017 Q2.

Falls, Older Adults

The crude death rate for falls in adults aged 65 years and older was 58.0 in 2018 Q3, similar to the rate of 57.8 in 2017 Q3. The crude mortality rate for falls in older adults for the 12 months ending with 2018 Q3 was 61.8; this is higher than the year before, when it was 60.8 for the 12 months ending 2017 Q3.

The age-adjusted mortality rates for falls in older individuals was 60.3 in 2018 Q3 and 59.5 in 2017 Q3. The age-adjusted death rates for falls in those aged 65 years and older for the 12 months ending with 2018 Q3 was 64.0, compared with 62.5 for the 12 months ending with 2017 Q3.

Firearm-Related Injury

The crude mortality rate for injuries related to firearms was 12.4 in 2018 Q3 and in 2017 Q3. The crude death rate for firearm-related injuries for the 12 months ending 2018 Q3 was 12.2 and 12.1 for the 12 months ending with 2017 Q3.

The age-adjusted mortality rate for firearm-associated injury for the 12 months ending with 2018 Q3 was 12.0, compared with 11.9 for the 12 months ending with 2017 Q3.

HIV Disease

The crude death rate for HIV disease rose slightly from 1.6 in 2018 Q4 to 1.7 in 2017 Q4. The crude mortality rate rose from 1.6 for the 12 months ending with 2018 Q4 to 1.7 for the 12 months ending with 2017 Q4.

The age-adjusted mortality rate for HIV disease was 1.4 in 2018 Q4 and rose to 1.6 in 2017 Q4. The age-adjusted death rate for HIV disease for the 12 months ending with 2018 Q4 was 1.5 and rose slightly to 1.6 for the 12 months ending with 2017 Q4.

Heart Disease

The crude mortality rate for heart disease dipped from to 202.1 in 2017 Q4 to 197.0 in 2018 Q4. The crude death rate for heart disease for the 12 months ending with 2018 Q4 was 198.6 and was similar at 198.8 for the 12 months ending with 2017 Q4.

The age-adjusted death rate for heart disease was 159.6 in 2018 Q4 — lower than that of 166.4 in 2017 Q4. The age-adjust mortality rate for heart disease during the 12 months ending with 2018 Q4 was 162.1, compared with 165.0 for the 12 months ending with 2017 Q4.

Homicide

The crude death rate for homicide was 5.9 in 2018 Q3 and 6.1 in 2017 Q3. The crude mortality rate for the 12 months ending with 2018 Q3 was 5.8, lower than the crude death rate of 6.0 for the 12 months ending with 2017 Q3.

The age-adjusted mortality rate for homicide was 6.0 in 2018 Q3 and 6.3 in 2017 Q3. The age-adjusted death rate for homicide for the 12 month period ending with 2018 Q3 was 6.0, lower than the 6.2 rate for the 12 months ending with 2017 Q3.

Hypertension

The crude death rate for hypertension was 10.9 in 2018 Q4, lower than that of 11.3 in 2017 Q4. The crude mortality rate was 10.9 for the 12 months ending 2018 Q4 and 10.8 for the 12-month period ending with 2017 Q4.

The age-adjusted mortality rate for hypertension for the 12 months ending 2018 Q4 decreased slightly from 9.0 for the 12 months ending 2017 Q4 to 8.9 for the 12 months ending 2018 Q4.

Influenza and Pneumonia

The crude mortality rate for influenza and pneumonia was 13.8 in 2018 Q4 and 16.5 in 2017 Q4. The crude death rate for influenza and pneumonia was 18.0 for the 12-month period ending with 1018 Q4 and 17.1 for the 12-month period ending with 2017 Q4.

The age-adjusted mortality rate for influenza and pneumonia was 11.2 in 2018 Q4, lower than the age-adjusted rate of 13.7 in 2017 Q4. The age-adjusted mortality rate for influenza and pneumonia for the 12 months ending with 2018 Q4 was 14.8 and 14.3 for the 12-month period ending with 2017 Q4.

Kidney Disease

The crude mortality rate for kidney disease was 15.6 in 2018 Q4 and 15.8 in 2017 Q4. The crude death rate for kidney disease during the 12 months ending with 2018 Q4 was 15.6 and 15.5 for the 12 months ending with 2017 Q4.

The age-adjusted mortality rate for kidney disease was 12.7 in 2018 Q4 and 13.1 in 2017 Q4. The age-adjusted death rate for kidney disease for the 12 months ending with 2018 Q4 was 12.8 – lower than the rate of 13.0 for the 12 months ending with 2017 Q4.

Parkinson Disease

The crude mortality rate for Parkinson disease was 10.7 in 2018 Q4 and 10.5 in 2017 Q4. The crude death rate for the 12 months ending with 2018 Q4 was 10.3, higher than that of 9.8 for the 12 months ending with 2017 Q4.

The age-adjusted mortality rate for Parkinson disease was 8.8 in 2018 Q4 and slightly higher, at 8.9, in 2017 Q4. The age-adjusted death rate for the 12 months ending with 2018 Q4 was 8.6, compared with 8.4 for the 12-month period ending with 2017 Q4.

Pneumonitis Due to Solids and Liquids

The crude mortality rate for pneumonitis due to solids and liquids was 5.6 in 2018 Q4 and 6.0 in 2017 Q4. For the 12-month period ending with 2018 Q4, the crude mortality rate was 5.9, lower than the rate of 6.2 for the 12 months ending with 2017 Q4.

The age-adjusted death rate for pneumonitis due to solids and liquids was 4.6 in 2018 Q4 and 4.9 in 2017 Q4.

The age-adjusted mortality rate for pneumonitis due to solids and liquids during the 12-month period ending with 2018 Q4 was 4.8, compared with 5.1 for the 12 months ending with 2017 Q4.

Septicemia

The crude mortality rate for septicemia was 12.2 in 2018 Q4 and 12.7 in 2017 Q4. The crude death rate for the 12 months ending with 2018 Q4 was 12.4; it was slightly higher at 12.6 for the 12 months ending with 2017 Q4.

The age-adjusted death rate for septicemia was 10.0 in 2018 Q4 and 10.6 in 2017 Q4. The age-adjusted mortality rate for the 12-month period ending with 2018 Q4 was 10.2; the rate was 10.6 for the 12 months ending with 2017 Q4.

Stroke

The crude mortality rate for stroke was 45.4 in 2018 Q4 and 46.4 in 2017 Q4.

The crude death rate for stroke for the 12 months ending with 2018 Q4 and for 2017 Q4 was 44.9 both years.

The age-adjusted mortality rate for stroke was 37.0 in 2018 Q4 and 38.5 in 2017 Q4. The age-adjusted death rate was 36.9 for the 12 months ending with 2017 Q4 and 37.6 for the 12 months ending with 2017 Q4.

Suicide

The crude mortality rate for suicide was 15.2 in 2018 Q3 and in 2017 Q3. The crude death rate for suicide for the 12 months ending with 2018 Q3 was 14.6; the rate was higher than the rate of 14.3 in the 12-month period ending with 2017 Q3.

The age-adjusted death rate for suicide was 14.7 in 2018 Q3 and in 2017 Q3. The age-adjusted mortality rate for suicide for the 12 months ending with 2018 Q3 was 14.1, compared with 13.8 for the 12 months ending with 2017 Q3.

Unintentional Injuries

The crude mortality rate for unintentional injuries was 50.5 in 2018 Q3 and 52.7 in 2017 Q3. The crude death rate for unintentional injuries for the 12 months ending with 2018 Q3 was 50.9 – lower than the crude death rate of 52.1 for the 12 months ending with 2017 Q3.

The age-adjusted mortality rate for unintentional injuries was 47.6 in 2018 Q3 and 50.0 in 2017 Q3. The age-adjusted mortality rate for unintentional injuries during the 12 months ending with 2018 Q3 was 47, lower than the 49.5 for the 12 months ending with 2017 Q3.

These data are publicly available at an interactive online dashboard from the NCHS.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube

Comments

3090D553-9492-4563-8681-AD288FA52ACE - alaskagarden.info - alaskagarden.info - alaskagarden.info - alaskagarden.info
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....